Cel Sci Corp Stock Performance
| CVM Stock | USD 0.67 0.02 2.91% |
The firm shows a Beta (market volatility) of -0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CEL SCI are expected to decrease at a much lower rate. During the bear market, CEL SCI is likely to outperform the market. At this point, CEL SCI Corp has a negative expected return of -0.71%. Please make sure to confirm CEL SCI's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if CEL SCI Corp performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:25 | Dividend Date 2017-06-15 | Ex Dividend Date 1996-08-28 | Last Split Date 2017-06-15 |
1 | CEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine in Head and Neck Cancer | 10/01/2024 |
2 | Disposition of 64000 shares by Gobbo Mario of CEL SCI at 1.5 subject to Rule 16b-3 | 10/14/2024 |
3 | FDAs Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCIs Multikine to Address Major Treatment Gap for PD-L1... | 10/22/2024 |
4 | CVM stock touches 52-week low at 0.68 amid sharp annual decline - Investing.com | 11/13/2024 |
5 | Acquisition by Daniel Zimmerman of 80000 shares of CEL SCI at 3.35 subject to Rule 16b-3 | 11/29/2024 |
6 | CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study | 12/12/2024 |
| Begin Period Cash Flow | 22.7 M |
CEL |
CEL SCI Relative Risk vs. Return Landscape
If you would invest 121.00 in CEL SCI Corp on September 17, 2024 and sell it today you would lose (52.00) from holding CEL SCI Corp or give up 42.98% of portfolio value over 90 days. CEL SCI Corp is generating negative expected returns assuming volatility of 5.7551% on return distribution over 90 days investment horizon. In other words, 51% of stocks are less volatile than CEL, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
CEL SCI Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CEL SCI's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CEL SCI Corp, and traders can use it to determine the average amount a CEL SCI's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1229
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CVM |
Estimated Market Risk
| 5.76 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.71 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CEL SCI is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CEL SCI by adding CEL SCI to a well-diversified portfolio.
CEL SCI Fundamentals Growth
CEL Stock prices reflect investors' perceptions of the future prospects and financial health of CEL SCI, and CEL SCI fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CEL Stock performance.
| Return On Equity | -2.5 | ||||
| Return On Asset | -0.61 | ||||
| Current Valuation | 55.77 M | ||||
| Shares Outstanding | 63.81 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 5.20 X | ||||
| Price To Sales | 11,797 X | ||||
| Gross Profit | (25.36 M) | ||||
| EBITDA | (27.56 M) | ||||
| Net Income | (32.19 M) | ||||
| Cash And Equivalents | 22.67 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 13.57 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 7.71 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (22.85 M) | ||||
| Earnings Per Share | (0.52) X | ||||
| Market Capitalization | 44.71 M | ||||
| Total Asset | 30.53 M | ||||
| Retained Earnings | (487.09 M) | ||||
| Working Capital | 1.33 M | ||||
| Current Asset | 5.89 M | ||||
| Current Liabilities | 4.01 M | ||||
About CEL SCI Performance
By examining CEL SCI's fundamental ratios, stakeholders can obtain critical insights into CEL SCI's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CEL SCI is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 238.39 | 226.47 | |
| Return On Tangible Assets | (0.96) | (1.01) | |
| Return On Capital Employed | (1.45) | (1.52) | |
| Return On Assets | (0.95) | (1.00) | |
| Return On Equity | (2.82) | (2.96) |
Things to note about CEL SCI Corp performance evaluation
Checking the ongoing alerts about CEL SCI for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CEL SCI Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CEL SCI Corp generated a negative expected return over the last 90 days | |
| CEL SCI Corp has high historical volatility and very poor performance | |
| CEL SCI Corp has some characteristics of a very speculative penny stock | |
| CEL SCI Corp has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (32.19 M) with loss before taxes, overhead, and interest of (25.36 M). | |
| CEL SCI Corp has about 22.67 M in cash with (22.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| CEL SCI Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study |
- Analyzing CEL SCI's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CEL SCI's stock is overvalued or undervalued compared to its peers.
- Examining CEL SCI's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CEL SCI's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CEL SCI's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CEL SCI's stock. These opinions can provide insight into CEL SCI's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.